Aurora Cannabis (TSE:ACB) Sets New 1-Year High at $12.83

Shares of Aurora Cannabis Inc. (TSE:ACB) reached a new 52-week high on Tuesday . The company traded as high as C$12.83 and last traded at C$12.65, with a volume of 7322643 shares changing hands. The stock had previously closed at C$8.65.

Analysts Set New Price Targets

Several research analysts recently issued reports on the company. Jefferies Financial Group cut their target price on Aurora Cannabis from C$6.12 to C$4.95 and set a “hold” rating on the stock in a research report on Tuesday, February 27th. CIBC cut their price objective on shares of Aurora Cannabis to C$6.00 and set a “neutral” rating on the stock in a report on Wednesday, February 21st. Finally, Canaccord Genuity Group upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating and set a C$0.80 target price for the company in a research note on Friday, February 9th.

Aurora Cannabis Trading Up 46.2 %

The company has a debt-to-equity ratio of 18.51, a current ratio of 3.79 and a quick ratio of 2.48. The company has a market capitalization of C$689.93 million, a P/E ratio of -0.16 and a beta of 2.83. The firm has a fifty day moving average price of C$6.44 and a 200-day moving average price of C$2.67.

Aurora Cannabis (TSE:ACB) last announced its quarterly earnings data on Thursday, February 8th. The company reported C($0.20) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of C($0.10) by C($0.10). The business had revenue of C$72.61 million during the quarter, compared to the consensus estimate of C$63.50 million. Aurora Cannabis had a net margin of 151.71% and a negative return on equity of 137.28%. On average, equities research analysts anticipate that Aurora Cannabis Inc. will post -0.22 earnings per share for the current year.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.